Product Description
Known For: A Boise integrative medicine practice offering a 9-peptide menu spanning regenerative, growth hormone, cognitive, and sexual wellness
| Location | Boise, Idaho |
| Address | 250 Bobwhite Court, Suite 110, Boise, ID 83706 |
| Phone | (208) 426-0052 |
| Website | imidaho.net |
| Treatments | BPC-157, TB4 fragment, KPV, Tesamorelin, CJC-Ipamorelin, MOTS-c, PT-141 (Bremelanotide), CJC-1295, Glutathione |
| Conditions Treated | Tissue repair, gut health, growth hormone support, metabolic optimization, sexual wellness, longevity |
| Administration | Subcutaneous injection |
| Cost | N/A |
| Insurance | N/A |
| Clinical Lead | Dr. Mary — Physician directing integrative medicine practice |
HealingMaps Take: A Boise integrative medicine practice offering a 9-peptide menu spanning regenerative, growth hormone, cognitive, and sexual wellness. Dr. Mary leads the clinical team and protocols are tailored to each patient’s goals after consultation.
About Integrative Medicine of Idaho
Integrative Medicine of Idaho operates in Boise, Idaho and offers peptide therapy. The clinic’s peptide menu includes bpc-157, tb4 fragment, kpv and related compounds, administered via subcutaneous injection.
For a closer look at how these compounds work, read our deep dives on how PT-141 is changing sexual health medicine and the CJC-1295 and Ipamorelin growth-hormone peptide stack.
See also the FDA’s 503A bulks list review of BPC-157, Semax, Epitalon and more.
What People Like
Dr. Mary’s integrative medicine practice publishes a specific 9-peptide menu including KPV and MOTS-c — compounds rare at other Boise clinics. The Bobwhite Court location serves central Boise.
What People Don’t Like
Full clinician name is not displayed publicly (referred to as “Dr Mary”). Pricing is set after consultation.
Getting Started at Integrative Medicine of Idaho
New patients call (208) 426-0052 to schedule with Dr. Mary at the Bobwhite Court Boise location.
Explore more peptide therapy clinics near you.


Reviews
There are no reviews yet.